Repressing miR-23a promotes the transdifferentiation of pancreatic α cells to β cells via negatively regulating the expression of SDF-1α.

Pancreatic β-cell failure is a pathological feature in type 1 diabetes. One promising approach involves inducing transdifferentiation of related pancreatic cell types, specifically α cells that produce glucagon. The chemokine stromal cell-derived factor-1 alpha (SDF-1α) is implicated in pancreatic α...

Full description

Bibliographic Details
Main Authors: Hongmei Lang, Ning Lin, Xiaorong Chen, Jie Xiang, Xingping Zhang, Chao Kang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0299821&type=printable
_version_ 1827572358345392128
author Hongmei Lang
Ning Lin
Xiaorong Chen
Jie Xiang
Xingping Zhang
Chao Kang
author_facet Hongmei Lang
Ning Lin
Xiaorong Chen
Jie Xiang
Xingping Zhang
Chao Kang
author_sort Hongmei Lang
collection DOAJ
description Pancreatic β-cell failure is a pathological feature in type 1 diabetes. One promising approach involves inducing transdifferentiation of related pancreatic cell types, specifically α cells that produce glucagon. The chemokine stromal cell-derived factor-1 alpha (SDF-1α) is implicated in pancreatic α-to-β like cell transition. Here, the serum level of SDF-1α was lower in T1D with C-peptide loss, the miR-23a was negatively correlated with SDF-1α. We discovered that exosomal miR-23a, secreted from β cells, functionally downregulates the expression of SDF-1α, leading to increased Pax4 expression and decreased Arx expression in vivo. Adenovirus-vectored miR-23a sponge and mimic were constructed to further explored the miR-23a on pancreatic α-to-β like cell transition in vitro, which yielded results consistent with our cell-based assays. Suppression of miR-23a upregulated insulin level and downregulated glucagon level in STZ-induced diabetes mice models, effectively promoting α-to-β like cell transition. Our findings highlight miR-23a as a new therapeutic target for regenerating pancreatic β cells from α cells.
first_indexed 2024-04-24T16:29:43Z
format Article
id doaj.art-c7a7d14211e84b548df6726d6a8f3632
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-24T16:29:43Z
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c7a7d14211e84b548df6726d6a8f36322024-03-30T05:33:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01193e029982110.1371/journal.pone.0299821Repressing miR-23a promotes the transdifferentiation of pancreatic α cells to β cells via negatively regulating the expression of SDF-1α.Hongmei LangNing LinXiaorong ChenJie XiangXingping ZhangChao KangPancreatic β-cell failure is a pathological feature in type 1 diabetes. One promising approach involves inducing transdifferentiation of related pancreatic cell types, specifically α cells that produce glucagon. The chemokine stromal cell-derived factor-1 alpha (SDF-1α) is implicated in pancreatic α-to-β like cell transition. Here, the serum level of SDF-1α was lower in T1D with C-peptide loss, the miR-23a was negatively correlated with SDF-1α. We discovered that exosomal miR-23a, secreted from β cells, functionally downregulates the expression of SDF-1α, leading to increased Pax4 expression and decreased Arx expression in vivo. Adenovirus-vectored miR-23a sponge and mimic were constructed to further explored the miR-23a on pancreatic α-to-β like cell transition in vitro, which yielded results consistent with our cell-based assays. Suppression of miR-23a upregulated insulin level and downregulated glucagon level in STZ-induced diabetes mice models, effectively promoting α-to-β like cell transition. Our findings highlight miR-23a as a new therapeutic target for regenerating pancreatic β cells from α cells.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0299821&type=printable
spellingShingle Hongmei Lang
Ning Lin
Xiaorong Chen
Jie Xiang
Xingping Zhang
Chao Kang
Repressing miR-23a promotes the transdifferentiation of pancreatic α cells to β cells via negatively regulating the expression of SDF-1α.
PLoS ONE
title Repressing miR-23a promotes the transdifferentiation of pancreatic α cells to β cells via negatively regulating the expression of SDF-1α.
title_full Repressing miR-23a promotes the transdifferentiation of pancreatic α cells to β cells via negatively regulating the expression of SDF-1α.
title_fullStr Repressing miR-23a promotes the transdifferentiation of pancreatic α cells to β cells via negatively regulating the expression of SDF-1α.
title_full_unstemmed Repressing miR-23a promotes the transdifferentiation of pancreatic α cells to β cells via negatively regulating the expression of SDF-1α.
title_short Repressing miR-23a promotes the transdifferentiation of pancreatic α cells to β cells via negatively regulating the expression of SDF-1α.
title_sort repressing mir 23a promotes the transdifferentiation of pancreatic α cells to β cells via negatively regulating the expression of sdf 1α
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0299821&type=printable
work_keys_str_mv AT hongmeilang repressingmir23apromotesthetransdifferentiationofpancreaticacellstobcellsvianegativelyregulatingtheexpressionofsdf1a
AT ninglin repressingmir23apromotesthetransdifferentiationofpancreaticacellstobcellsvianegativelyregulatingtheexpressionofsdf1a
AT xiaorongchen repressingmir23apromotesthetransdifferentiationofpancreaticacellstobcellsvianegativelyregulatingtheexpressionofsdf1a
AT jiexiang repressingmir23apromotesthetransdifferentiationofpancreaticacellstobcellsvianegativelyregulatingtheexpressionofsdf1a
AT xingpingzhang repressingmir23apromotesthetransdifferentiationofpancreaticacellstobcellsvianegativelyregulatingtheexpressionofsdf1a
AT chaokang repressingmir23apromotesthetransdifferentiationofpancreaticacellstobcellsvianegativelyregulatingtheexpressionofsdf1a